# Keith Flaherty

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/Keith_Flaherty
> Markdown URL: https://mediated.wiki/source/Keith_Flaherty.md
> Source: https://en.wikipedia.org/wiki/Keith_Flaherty
> Source revision: 1318130585
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

{{short description|Professor of medicine}}
'''Keith Flaherty''' is Director of Clinical Research at the [Massachusetts General Hospital](/source/Massachusetts_General_Hospital) Cancer Center and Professor of Medicine at [Harvard Medical School](/source/Harvard_Medical_School).<ref>[http://www.massgeneral.org/cancer/doctors/doctor.aspx?ID=18371 Keith T. Flaherty, MD - Massachusetts General Hospital, Boston, MA]</ref> He was previously a professor of medicine at the [University of Pennsylvania](/source/University_of_Pennsylvania).  He is known for his research on [targeted therapies](/source/targeted_therapies) for [cancer](/source/cancer), and in particular for his work on the [melanoma](/source/melanoma) drug [vemurafenib](/source/vemurafenib).<ref>[https://www.nytimes.com/2010/02/22/health/research/22trial.html?em Target Cancer - A Roller Coaster Chase for a Cure - Series - NYTimes.com]</ref><ref>[https://www.nytimes.com/2010/02/23/health/research/23trial.html?hp Target Cancer - After Long Fight, Melanoma Drug Gives Sudden Reprieve - Series - NYTimes.com]</ref><ref>[https://www.nytimes.com/2010/02/24/health/research/24trial.html?hpw Target Cancer - A Drug Trial Cycle - Recovery, Relapse, Reinvention - Series - NYTimes.com]</ref><ref>[http://www.nejm.org/doi/full/10.1056/NEJMoa1002011 Inhibition of Mutated, Activated BRAF in Metastatic Melanoma — NEJM]</ref> In 2013, Massachusetts General Hospital partnered with [AstraZeneca](/source/AstraZeneca) to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs.<ref>{{cite web | url=https://www.bostonglobe.com/business/2013/05/19/for-cancer-patients-better-match-with-treatments/XNn4LlLGy8K3pArkjezMrM/story.html | title=MGH, AstraZeneca partner to create new drug combos | work=Boston Globe | date=19 May 2013 | accessdate=30 January 2015 | author=Weintraub, Karen | archive-date=8 April 2015 | archive-url=https://web.archive.org/web/20150408001649/http://www.bostonglobe.com/business/2013/05/19/for-cancer-patients-better-match-with-treatments/XNn4LlLGy8K3pArkjezMrM/story.html | url-status=dead }}</ref>

==References==
{{Reflist}}

{{Authority control}}

{{DEFAULTSORT:Flaherty, Keith}}
Category:Year of birth missing (living people)
Category:University of Pennsylvania faculty
Category:Living people
Category:Harvard Medical School faculty
Category:American cancer researchers

---
Adapted from the Wikipedia article [Keith Flaherty](https://en.wikipedia.org/wiki/Keith_Flaherty) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/Keith_Flaherty?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.